Compared with the AKI-CONTROL group, the expression of protein Bcl-2 increased in the sham and all three intervention groups, and we clearly found that the increase of Bcl-2 in the administration group even exceeded that in the sham group, while Bcl-2 in the combined treatment group was the highest. Here, BCL2 is linked to acute kidney injury.